TFX Stock Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for TFX from our risk checks.
My Notes
NewNotes are coming soon
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$258.47 |
| 52 Week High | US$356.72 |
| 52 Week Low | US$182.65 |
| Beta | 1.02 |
| 1 Month Change | 0.21% |
| 3 Month Change | 28.71% |
| 1 Year Change | -17.62% |
| 3 Year Change | -31.40% |
| 5 Year Change | 1.28% |
| Change since IPO | 2,391.28% |
Recent News & Updates
Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns
Jan 27
Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet
Jan 12Teleflex Already Getting A Pretty Good Benefit Of The Doubt
Jan 11Recent updates
Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns
Jan 27Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet
Jan 12Teleflex Already Getting A Pretty Good Benefit Of The Doubt
Jan 11An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued
Dec 28What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Dec 12Teleflex recalls over 2.7M bacterial filters – FDA
Nov 01Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy
Oct 25Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)
Oct 17Is Teleflex (NYSE:TFX) Using Too Much Debt?
Oct 03Is Teleflex Incorporated (NYSE:TFX) Trading At A 44% Discount?
Sep 05Teleflex to acquire Standard Bariatrics for $170M
Aug 22Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching
Aug 08Telefex: Valuations Are Stretched, Lack Of Risk Premia To Harvest
Jul 25Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger
Jul 12Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate
Jul 01Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?
Jun 27Are Investors Undervaluing Teleflex Incorporated (NYSE:TFX) By 37%?
May 30Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
May 02Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Apr 06Is Teleflex (NYSE:TFX) Using Too Much Debt?
Mar 24Teleflex: Diversified Portfolio Of Medical Devices At A Convenient Stock Price
Mar 23Is Teleflex Incorporated (NYSE:TFX) Trading At A 24% Discount?
Feb 27Do Teleflex's (NYSE:TFX) Earnings Warrant Your Attention?
Feb 14Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Jan 03Is Teleflex (NYSE:TFX) A Risky Investment?
Dec 21Teleflex Is Now Trading At Fair Value
Dec 14Returns On Capital At Teleflex (NYSE:TFX) Have Stalled
Nov 30Is Teleflex Incorporated (NYSE:TFX) Trading At A 33% Discount?
Nov 17Does Teleflex (NYSE:TFX) Deserve A Spot On Your Watchlist?
Nov 04Is There Now An Opportunity In Teleflex Incorporated (NYSE:TFX)?
Sep 22We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt
Sep 07Returns On Capital Signal Tricky Times Ahead For Teleflex (NYSE:TFX)
Aug 23Calculating The Intrinsic Value Of Teleflex Incorporated (NYSE:TFX)
Aug 08Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching
Jun 22We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt
Jun 07Returns On Capital Signal Tricky Times Ahead For Teleflex (NYSE:TFX)
May 21Teleflex declares $0.34 dividend
May 03Teleflex Q1 2021 Earnings Preview
Apr 28We Take A Look At Whether Teleflex Incorporated's (NYSE:TFX) CEO May Be Underpaid
Apr 23Calculating The Intrinsic Value Of Teleflex Incorporated (NYSE:TFX)
Mar 22Shareholder Returns
| TFX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.2% | 3.8% | 1.7% |
| 1Y | -17.6% | -9.3% | -9.6% |
Return vs Industry: TFX underperformed the US Medical Equipment industry which returned -9.3% over the past year.
Return vs Market: TFX underperformed the US Market which returned -9.6% over the past year.
Price Volatility
| TFX volatility | |
|---|---|
| TFX Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: TFX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,000 | Liam Kelly | https://www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| TFX fundamental statistics | |
|---|---|
| Market Cap | US$12.12b |
| Earnings (TTM) | US$412.27m |
| Revenue (TTM) | US$2.79b |
29.4x
P/E Ratio4.3x
P/S RatioIs TFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TFX income statement (TTM) | |
|---|---|
| Revenue | US$2.79b |
| Cost of Revenue | US$1.27b |
| Gross Profit | US$1.53b |
| Other Expenses | US$1.12b |
| Earnings | US$412.27m |
Last Reported Earnings
Sep 25, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.79 |
| Gross Margin | 54.67% |
| Net Profit Margin | 14.75% |
| Debt/Equity Ratio | 43.8% |
How did TFX perform over the long term?
See historical performance and comparison